Wealth Alliance LLC cut its holdings in Morgan Stanley (NYSE:MS – Free Report) by 60.6% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,290 shares of the financial services provider’s stock after selling 3,519 shares during the period. Wealth Alliance LLC’s holdings in Morgan Stanley were worth $364,000 at the end of the most recent quarter.
Other large investors have also added to or reduced their stakes in the company. Bedel Financial Consulting Inc. raised its position in Morgan Stanley by 2.1% during the third quarter. Bedel Financial Consulting Inc. now owns 3,120 shares of the financial services provider’s stock worth $496,000 after acquiring an additional 63 shares in the last quarter. Moss Adams Wealth Advisors LLC increased its stake in shares of Morgan Stanley by 0.5% during the 3rd quarter. Moss Adams Wealth Advisors LLC now owns 13,222 shares of the financial services provider’s stock worth $2,102,000 after purchasing an additional 65 shares during the last quarter. Hanson & Doremus Investment Management raised its holdings in shares of Morgan Stanley by 8.1% in the 3rd quarter. Hanson & Doremus Investment Management now owns 877 shares of the financial services provider’s stock valued at $139,000 after purchasing an additional 66 shares during the period. LeConte Wealth Management LLC raised its holdings in shares of Morgan Stanley by 3.7% in the 3rd quarter. LeConte Wealth Management LLC now owns 1,841 shares of the financial services provider’s stock valued at $293,000 after purchasing an additional 66 shares during the period. Finally, Watts Gwilliam & Co. LLC lifted its stake in Morgan Stanley by 2.3% in the 2nd quarter. Watts Gwilliam & Co. LLC now owns 3,090 shares of the financial services provider’s stock valued at $435,000 after purchasing an additional 68 shares during the last quarter. Institutional investors and hedge funds own 84.19% of the company’s stock.
Key Morgan Stanley News
Here are the key news stories impacting Morgan Stanley this week:
- Positive Sentiment: Q4 2025 earnings beat — Morgan Stanley reported $2.68 diluted EPS (above $2.28 consensus) and $17.9B revenue (above consensus), with profit and ROE improving versus year-ago results. That beat supports valuation multiples and investor confidence in core businesses. Morgan Stanley Q4 2025 earnings (Quiver)
- Positive Sentiment: Morgan Stanley Wealth Management is cutting transaction fees on private-share trading via its EquityZen marketplace, widening access to private markets for clients and potentially increasing platform volume and AUM-driven fees over time. This is a strategic, client-facing fee action that supports recurring fee growth. MS press release: EquityZen fee reduction
- Neutral Sentiment: Institutional positioning and research influence — filings and press coverage show Morgan Stanley increasing certain crypto-related stakes (e.g., BitMine) and remaining active with analyst coverage (initiations/ratings across GE, CoreWeave, etc.). These activities highlight diversified revenue/alpha generation but carry mixed risk/reward. Wall Street boosts Bitmine stakes (Cointelegraph)
- Neutral Sentiment: Research calls can move sectors — recent Morgan Stanley analyst notes (e.g., cautious stance ahead of CoreWeave earnings, new coverage of GE Aerospace) underscore the firm’s market influence; that can amplify short-term flows but is not a direct corporate catalyst for MS itself. TipRanks: Morgan Stanley on CoreWeave
- Negative Sentiment: Reputational/legal risk — reporting that Morgan Stanley opened accounts for Epstein-related trusts as late as 2019 could raise regulatory or reputational questions and short-term investor caution, particularly if follow-up scrutiny or legal exposure emerges. Yahoo Finance: Morgan Stanley opened accounts for Epstein trusts
- Negative Sentiment: Cash-flow and insider activity flagged in the quarter — while EPS/revenue beat, cash from operating activities swung materially negative (reported roughly -$2.4B) and the company disclosed multiple insider stock sales in recent filings. Those items can temper enthusiasm and are reasons some investors may trim positions despite the headline beat. Morgan Stanley Q4 2025 earnings (Quiver)
Morgan Stanley Price Performance
Morgan Stanley (NYSE:MS – Get Free Report) last posted its quarterly earnings data on Thursday, January 15th. The financial services provider reported $2.68 EPS for the quarter, topping analysts’ consensus estimates of $2.28 by $0.40. Morgan Stanley had a return on equity of 16.92% and a net margin of 14.09%.The company had revenue of $17.90 billion for the quarter, compared to analyst estimates of $17.69 billion. During the same period in the previous year, the firm earned $2.22 earnings per share. The firm’s quarterly revenue was up 10.3% on a year-over-year basis. Research analysts predict that Morgan Stanley will post 8.56 earnings per share for the current fiscal year.
Morgan Stanley Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, February 13th. Shareholders of record on Friday, January 30th were given a $1.00 dividend. This represents a $4.00 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date of this dividend was Friday, January 30th. Morgan Stanley’s dividend payout ratio is presently 39.18%.
Insiders Place Their Bets
In other news, insider Andrew M. Saperstein sold 30,330 shares of Morgan Stanley stock in a transaction on Tuesday, January 20th. The stock was sold at an average price of $183.62, for a total transaction of $5,569,194.60. Following the sale, the insider directly owned 280,481 shares in the company, valued at $51,501,921.22. The trade was a 9.76% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Charles A. Smith sold 8,500 shares of the stock in a transaction on Tuesday, January 20th. The stock was sold at an average price of $182.08, for a total value of $1,547,680.00. Following the transaction, the insider owned 119,128 shares of the company’s stock, valued at $21,690,826.24. The trade was a 6.66% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 129,191 shares of company stock worth $23,736,506 in the last ninety days. 0.19% of the stock is owned by corporate insiders.
Analysts Set New Price Targets
MS has been the subject of a number of research analyst reports. Keefe, Bruyette & Woods boosted their price objective on Morgan Stanley from $202.00 to $210.00 and gave the stock a “moderate buy” rating in a report on Friday, January 16th. Wells Fargo & Company boosted their price target on Morgan Stanley from $177.00 to $189.00 and gave the company an “equal weight” rating in a research note on Monday, January 5th. Wolfe Research reiterated an “outperform” rating and set a $211.00 price objective on shares of Morgan Stanley in a research report on Wednesday, January 7th. Wall Street Zen raised shares of Morgan Stanley from a “hold” rating to a “buy” rating in a research report on Friday, January 23rd. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Morgan Stanley from $157.00 to $162.00 and gave the stock a “neutral” rating in a research note on Thursday, January 8th. Three equities research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat, Morgan Stanley presently has a consensus rating of “Moderate Buy” and an average price target of $185.93.
Check Out Our Latest Report on Morgan Stanley
Morgan Stanley Profile
Morgan Stanley (NYSE: MS) is a global financial services firm headquartered in New York City. Founded in 1935 by Henry S. Morgan and Harold Stanley, the company provides a broad range of investment banking, securities, wealth management and investment management services to corporations, governments, institutions and individual investors. Leadership has been guided by a senior executive team and board of directors; James P. Gorman has served as the company’s chief executive and chairman in recent years.
The firm’s primary business activities are organized around three principal businesses: Institutional Securities, Wealth Management and Investment Management.
Recommended Stories
- Five stocks we like better than Morgan Stanley
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- America’s 1776 happening again
- How a Family Trust May Be Able To Help Preserve Your Wealth
- This makes me furious
- Elon Musk: This Could Turn $100 into $100,000
Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS – Free Report).
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.
